MoneyWorks4Me

The revenue zoomed 19.95% to Rs. 227.21 millions for the quarter ended March 2023 as compared to Rs. 189.42 millions during the corresponding quarter last year.Profit for the quarter ended March 2023 increased merely by1.27% to Rs. 19.11  millions from Rs. 18.87 millions.Operating profit for the quarter ended March 2023 rose to 28.63 millions as compared to 18.87 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 227.21 189.42 19.95 744.57 693.94 7.30 744.57 693.94 7.30
Other Income 3.35 1.94 72.68 8.41 8.82 -4.65 8.41 8.82 -4.65
PBIDT 28.63 18.87 51.72 117.94 99.62 18.39 117.94 99.62 18.39
Interest 0.74 0.31 138.71 1.58 2.25 -29.78 1.58 2.25 -29.78
PBDT 27.89 23.06 20.95 116.36 101.87 14.22 116.36 101.87 14.22
Depreciation 1.32 1.48 -10.81 5.69 6.33 -10.11 5.69 6.33 -10.11
PBT 26.57 21.58 23.12 110.67 95.54 15.84 110.67 95.54 15.84
TAX 7.46 2.71 175.28 28.63 23.31 22.82 28.63 23.31 22.82
Deferred Tax 0.18 -0.50 -136.00 -0.07 -0.01 600.00 -0.07 -0.01 600.00
PAT 19.11 18.87 1.27 82.04 72.23 13.58 82.04 72.23 13.58
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 12.60 9.96 26.49 15.84 14.36 10.34 15.84 14.36 10.34
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..